GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Filament Health Corp (OTCPK:FLHLF) » Definitions » EV-to-FCF

FLHLF (Filament Health) EV-to-FCF : -1.82 (As of Mar. 17, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Filament Health EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Filament Health's Enterprise Value is $4.14 Mil. Filament Health's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was $-2.28 Mil. Therefore, Filament Health's EV-to-FCF for today is -1.82.

The historical rank and industry rank for Filament Health's EV-to-FCF or its related term are showing as below:

FLHLF' s EV-to-FCF Range Over the Past 10 Years
Min: -9.37   Med: -3.11   Max: -1.33
Current: -1.94

During the past 4 years, the highest EV-to-FCF of Filament Health was -1.33. The lowest was -9.37. And the median was -3.11.

FLHLF's EV-to-FCF is ranked worse than
100% of 552 companies
in the Drug Manufacturers industry
Industry Median: 23.465 vs FLHLF: -1.94

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-17), Filament Health's stock price is $0.0165. Filament Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.016. Therefore, Filament Health's PE Ratio (TTM) for today is At Loss.


Filament Health EV-to-FCF Historical Data

The historical data trend for Filament Health's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Filament Health EV-to-FCF Chart

Filament Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- -7.66 -2.03 -4.39

Filament Health Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.43 -4.39 -1.81 -2.89 -3.14

Competitive Comparison of Filament Health's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Filament Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Filament Health's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Filament Health's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Filament Health's EV-to-FCF falls into.



Filament Health EV-to-FCF Calculation

Filament Health's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=4.137/-2.278
=-1.82

Filament Health's current Enterprise Value is $4.14 Mil.
Filament Health's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Filament Health  (OTCPK:FLHLF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Filament Health's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0165/-0.016
=At Loss

Filament Health's share price for today is $0.0165.
Filament Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.016.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Filament Health EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Filament Health's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Filament Health Business Description

Traded in Other Exchanges
Address
4475 Wayburne Drive, Unit 210, Burnaby, BC, CAN, V5G 4X4
Filament Health Corp is a natural psychedelic drug development company. Its mission is to see safe, approved, natural psychedelics in the hands of everyone who needs them as soon as possible. The group engages in natural extraction technology commercialization, utilizing its intellectual property portfolio, in-house GMP facility, and Health Canada psilocybin Dealer's License.

Filament Health Headlines